Get started
Author

Fulden Akyüz İnanç

Observed names: Fulden AKYÜZ İNANÇ, Fulden Akyuz Inanc
ORCID: 0000-0002-2327-3349
Observed ORCID: 0000-0002-2327-3349
OpenAlex ID: A5066824102
900.23 Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in Frail Atrial Fibrillation Patients: A Propensity-Matched Global Trinetx Analysis
2026 · Ibrahim Halil Inanc, Martin Dominguez, et al. · JACC: Cardiovascular Interventions · 1
CALLY index in patients admitted in the intensive care unit with a diagnosis of decompensated heart failure
2025 · Elif Eygi, Sedat Sakallı, et al. · Ankyra Medical Journal · 1
26-a-11488-acc Impact of Obstructive Sleep Apnea on Adverse Cardiovascular Outcomes in Patients With Atrial Fibrillation: a Real-world Cohort Study
2026 · Fulden Akyuz Inanc, Ibrahim Halil Inanc, et al. · Journal of the American College of Cardiology
100.09 Extended Versus Short-term DAPT After ACS In Cancer Patients: A Global Real-World Analysis
2026 · Ibrahim Halil Inanc, Afnan Chaudhry, et al. · JACC: Cardiovascular Interventions
100.08 Invasive Vs Conservative Management in Cancer Patients With NSTEMI: A Global Propensity-Matched Trinetx Analysis
2026 · Ibrahim Halil Inanc, Afnan Chaudhry, et al. · JACC: Cardiovascular Interventions
900.03 Aspirin Versus No Antiplatelet Therapy After TAVR in Very Elderly High-Bleeding-Risk Patients: A Propensity-Matched Global Cohort Study
2026 · Ibrahim Halil Inanc, Ozge Tasgin Yildirim, et al. · JACC: Cardiovascular Interventions
900.08 Impact Of Active or Prior Cancer on Clinical Outcomes After TAVR: A Real-World Propensity-Matched Analysis
2026 · Ibrahim Halil Inanc, Mehmet Cilingiroglu, et al. · JACC: Cardiovascular Interventions
200.06 Prognostic Impact of Atrial Fibrillation in Cancer Patients Presenting with Acute Coronary Syndromes: A Global Propensity-Matched Analysis
2026 · Ibrahim Halil Inanc, Afnan Chaudhry, et al. · JACC: Cardiovascular Interventions
200.07 Impact of Atrial Fibrillation on One-Year Mortality in Cancer Patients: A Global Propensity-Matched Analysis
2026 · Ibrahim Halil Inanc, Mehmet Cilingiroglu, et al. · JACC: Cardiovascular Interventions
200.09 DOACS vs Warfarin After TAVR in Atrial Fibrillation: A Global Propensity-Matched Outcomes Study
2026 · Ibrahim Halil Inanc, Asigul Yimit, et al. · JACC: Cardiovascular Interventions
100.15 Impact of Baseline Anemia on Mortality and Cardiovascular Outcomes After Percutaneous Coronary Intervention: A Multicenter Real-World Study
2026 · Ibrahim Halil Inanc, Ozge Taskin Yildirim, et al. · JACC: Cardiovascular Interventions
400.05 Long-term Survival Benefit of GLP-1 Agonists In Heart-Transplant Recipients: A Propensity-matched Real-World Analysis
2026 · Afnan Chaudhry, Olutoyin M. Lawal, et al. · JACC: Cardiovascular Interventions
600.07 Cardiovascular Adverse Events Associated With Immune Checkpoint Inhibitors: A Global Propensity-Matched Analysis
2026 · Ibrahim Halil Inanc, Afnan Chaudhry, et al. · JACC: Cardiovascular Interventions
A Novel Biomarker to Predict the Risk of Contrastinduced Nephropathy in Patients Undergoing Coronary Angiography: Total Bilirubin Phosphorus Ratio
2026 · Mesut Karataş, İbrahim Halil İnanç, et al. · Koşuyolu Heart Journal
PDF
Long-Term Survival Benefit Of GLP-1 Receptor Agonists In Heart Transplant Recipients: A Propensity-Matched Real-World Analysis
2026 · Afnan Chaudhry, Ibrahim Inanc, et al. · SSRN Electronic Journal
Predictive value of c-reactive protein to albumin ratio and systemic immune-inflammation index for the long-term mortality in COVID-19
2023 · Esra POLAT, Cengiz ŞABANOĞLU, et al. · Journal of Medicine and Palliative Care
PDF
Works count: 16
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type